Vaccine News and Research

Latest Vaccine News and Research

First enzyme-driven biocatalytic production of nucleic acid building blocks

Researchers from TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of nucleic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics.

15 Dec 2020

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

A machine learning algorithm developed by the Oxford Vaccine Group promises more effective vaccine development for several diseases, including COVID-19.

15 Dec 2020

UK government declares identification of a “new variant” of coronavirus

The UK government has released a statement that a “new variant” of coronavirus that could be causing a faster spread of the virus has been identified.

15 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

SLS and Eppendorf to supply ultra-low temperature freezers for UK COVID-19 vaccines

Scientific Laboratory Supplies and Eppendorf have been chosen to provide ultra-low temperature freezers for the country’s supply of COVID-19 vaccines.

15 Dec 2020

Scientists empower wireless sensors with vision abilities to fight viruses

Current and former early-career scientists share their stories and tell how Europe has bet on them, making their high-risk research possible: from intelligent wireless sensors with vision abilities to RNA-based techniques to fight viruses, from the mathematical formulas of the MRI waves to optoceutics, the new technique that uses light to repair the heart after a stroke.

15 Dec 2020

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis, and middle-ear infections.

15 Dec 2020

Pandemic backlash jeopardizes public health powers, leaders

A series examining how the U.S. public health front lines have been left understaffed and ill-prepared to save us from the coronavirus pandemic.

15 Dec 2020

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

The light at the end of the pandemic tunnel is getting brighter. This week, the first health care workers will receive the first doses of an FDA-approved coronavirus vaccine. Soon, so will other front-line workers in health care and beyond, and residents of long-term care facilities.

15 Dec 2020

COVID-19 vaccine shows the long-term value of curiosity-driven basic research

The most promising vaccine against the coronavirus to date is also an example of the long-term value of curiosity-driven basic research and its funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

15 Dec 2020

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it?

14 Dec 2020

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

14 Dec 2020

The effect of vaccination on the spread of COVID-19 disease

Researchers from Cornell University, USA, have modeled the effect of vaccination on the spread of COVID-19 disease. They suggest that vaccinating healthcare workers first followed by people who have many social interactions, such as grocers and airline cabin crew, will help reduce transmission. The research is published on the preprint server medRxiv*, prior to peer review.

14 Dec 2020

Behavioral strategies for the promotion of COVID-19 vaccines

National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at "warp speed" will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.

14 Dec 2020

UHN gave first COVID-19 vaccine in Canada

University Health Network today gave the first COVID-19 vaccine in Canada. This landmark event signals a potential turning point in the pandemic and underlines the value of science and worldwide cooperation.

14 Dec 2020

New method shortens the timeline to generate mice for vaccine research

To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized antibodies bound to the B cell membrane.

14 Dec 2020

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

The onslaught of the COVID-19 pandemic, the hunt for a drug, and the successful development of a vaccine has impacted people beyond measure worldwide.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

The focus is increasingly moving towards vaccine roll-out as the world faces the real possibility of the second year of social and economic restrictions.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Vaccine News and Research

Latest Vaccine News and Research

First enzyme-driven biocatalytic production of nucleic acid building blocks

SIMON – The Machine Learning Platform Paving the Future of Vaccine Development

UK government declares identification of a “new variant” of coronavirus

Reliable Antibodies Testing for SARS-CoV-2

SLS and Eppendorf to supply ultra-low temperature freezers for UK COVID-19 vaccines

Scientists empower wireless sensors with vision abilities to fight viruses

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Pandemic backlash jeopardizes public health powers, leaders

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

COVID-19 vaccine shows the long-term value of curiosity-driven basic research

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

The effect of vaccination on the spread of COVID-19 disease

Behavioral strategies for the promotion of COVID-19 vaccines

UHN gave first COVID-19 vaccine in Canada

New method shortens the timeline to generate mice for vaccine research

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Emergence of resistant SARS-CoV-2 variant in immunocompromised patient following therapeutic antibody use

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in